Daniel M. Witt

7.9k total citations · 2 hit papers
153 papers, 4.5k citations indexed

About

Daniel M. Witt is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Hematology. According to data from OpenAlex, Daniel M. Witt has authored 153 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 114 papers in Cardiology and Cardiovascular Medicine, 85 papers in Internal Medicine and 16 papers in Hematology. Recurrent topics in Daniel M. Witt's work include Atrial Fibrillation Management and Outcomes (98 papers), Venous Thromboembolism Diagnosis and Management (85 papers) and Blood Pressure and Hypertension Studies (20 papers). Daniel M. Witt is often cited by papers focused on Atrial Fibrillation Management and Outcomes (98 papers), Venous Thromboembolism Diagnosis and Management (85 papers) and Blood Pressure and Hypertension Studies (20 papers). Daniel M. Witt collaborates with scholars based in United States, Canada and Italy. Daniel M. Witt's co-authors include Mark Crowther, Nathan P. Clark, Thomas Delate, Anne Holbrook, Gordon Guyatt, Sam Schulman, David García, Per Olav Vandvik, Jason Fish and David L. Veenstra and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Daniel M. Witt

143 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evidence-Based Management of Anticoagulant Therapy

2012 887 citations Anne Holbrook, Sam Schulman et al. profile →
American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy

2018 329 citations Daniel M. Witt, Robby Nieuwlaat et al. Blood Advances profile →

Peers

Daniel M. Witt

CCM

SURGE

EPIDE

HEMAT

Alan K. Jacobson United States

Scott Kaatz United States

John Fanikos United States

Geoffrey D. Barnes United States

Edith A. Nutescu United States

F.J.M. van der Meer Netherlands

Sarah A. Spinler United States

David Fitzmaurice United Kingdom

William E. Dager United States

Geno J. Merli United States

Alan K. Jacobson United States

Daniel M. Witt

4.4k ×1.4

CCM

2.2k ×1.0

717 ×1.2

SURGE

470 ×1.0

EPIDE

362 ×0.9

HEMAT

Citations per year, relative to Daniel M. Witt Daniel M. Witt (= 1×) peers Alan K. Jacobson

Countries citing papers authored by Daniel M. Witt

Since Specialization

Citations

This map shows the geographic impact of Daniel M. Witt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel M. Witt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel M. Witt more than expected).

Fields of papers citing papers by Daniel M. Witt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel M. Witt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel M. Witt. The network helps show where Daniel M. Witt may publish in the future.

Co-authorship network of co-authors of Daniel M. Witt

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel M. Witt. A scholar is included among the top collaborators of Daniel M. Witt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel M. Witt. Daniel M. Witt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jones, Aubrey E., et al.. (2023). A qualitative study evaluating provider perceptions of implementing warfarin patient self‐management in the United States healthcare system. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 6(12). 1295–1303. 1 indexed citations

Witt, Daniel M., et al.. (2023). Venous thromboembolism management in people with cystic fibrosis. Pediatric Pulmonology. 59(3). 584–591. 1 indexed citations

Jones, Aubrey E., et al.. (2023). A qualitative study exploring patient experiences and opinions of warfarin patient self‐management in the US healthcare system. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 7(3). 198–206.

Derington, Catherine G., Glenn K. Goodrich, Stanley Xu, et al.. (2023). Association of Direct Oral Anticoagulation Management Strategies With Clinical Outcomes for Adults With Atrial Fibrillation. JAMA Network Open. 6(7). e2321971–e2321971. 4 indexed citations

Vazquez, Sara R., et al.. (2022). Antiplatelet therapy indication in patients also prescribed direct oral anticoagulants. Journal of Thrombosis and Thrombolysis. 55(1). 185–188. 4 indexed citations

Jones, Aubrey, John Saunders, Sara R. Vazquez, Angela Fagerlin, & Daniel M. Witt. (2021). A survey of current anticoagulation patient education practices and development. Thrombosis Research. 208. 11–13. 1 indexed citations

Zhang, Junxian, Xiaojie Wang, Xintong Liu, et al.. (2021). Comparative effectiveness and safety of direct acting oral anticoagulants in nonvalvular atrial fibrillation for stroke prevention: a systematic review and meta-analysis. European Journal of Epidemiology. 36(8). 793–812. 15 indexed citations

Jones, Aubrey E., Jordan B. King, Kibum Kim, & Daniel M. Witt. (2020). The role of clinical pharmacy anticoagulation services in direct oral anticoagulant monitoring. Journal of Thrombosis and Thrombolysis. 50(3). 739–745. 7 indexed citations

Piran, Siavash, Rasha Khatib, Sam Schulman, et al.. (2019). Management of direct factor Xa inhibitor–related major bleeding with prothrombin complex concentrate: a meta-analysis. Blood Advances. 3(2). 158–167. 84 indexed citations

10.

Feehan, Michael, et al.. (2019). A descriptive study of antithrombotic medication patterns in adult patients with recent venous thromboembolism. Pharmacy Practice. 17(3). 1539–1539. 2 indexed citations

11.

Jones, Aubrey, et al.. (2019). Survey of current treatment practices for venous thromboembolism in patients with cystic fibrosis. Pediatric Pulmonology. 55(1). 149–155. 5 indexed citations

12.

Saunders, John, et al.. (2019). Real-world study of direct oral anticoagulant dosing patterns in patients with atrial fibrillation. Pharmacy Practice. 17(4). 1709–1709. 12 indexed citations

13.

Jones, Aubrey, et al.. (2019). Accuracy of ICD-10 codes for identifying hospitalizations for acute anticoagulation therapy-related bleeding events. Thrombosis Research. 181. 71–76. 39 indexed citations

14.

Kim, Kibum, et al.. (2019). Understanding patients’ care barriers in the treatment of venous thromboembolism. Journal of Thrombosis and Thrombolysis. 48(1). 35–41. 2 indexed citations

15.

Witt, Daniel M., Robby Nieuwlaat, Nathan P. Clark, et al.. (2018). American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy. Blood Advances. 2(22). 3257–3291. 329 indexed citations breakdown →

16.

Li, Guowei, Gregory Y.H. Lip, Anne Holbrook, et al.. (2018). Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies. European Journal of Epidemiology. 34(2). 173–190. 55 indexed citations

17.

King, Jordan B., Peyman N. Azadani, Promporn Suksaranjit, et al.. (2017). Left Atrial Fibrosis and Risk of Cerebrovascular and Cardiovascular Events in Patients With Atrial Fibrillation. Journal of the American College of Cardiology. 70(11). 1311–1321. 141 indexed citations

18.

Fang, Margaret C., Dongjie Fan, Daniel M. Witt, et al.. (2013). Abstract 12181: Pulmonary Embolism Outcomes After Discharge From the Emergency Department: The CVRN VTE Study. Circulation. 128. 2 indexed citations

19.

Witt, Daniel M.. (2011). Quality measures and benchmarking for warfarin therapy. Journal of Thrombosis and Thrombolysis. 31(3). 242–248. 4 indexed citations

20.

Witt, Daniel M., Thomas Delate, Mary Beth Dowd, et al.. (2009). Incidence and predictors of bleeding or thrombosis after polypectomy in patients receiving and not receiving anticoagulation therapy. Journal of Thrombosis and Haemostasis. 7(12). 1982–1989. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact